Alto Neuroscience, Inc. (ANRO) › Cash & EquivalentsAlto Neuroscience, Inc. (ANRO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: $82.55M2024: $168.23M2025: $176.48M$176.48M2023Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$176.48M+4.9%2024$168.23M+103.8%2023$82.55M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share